NOVACYT
NOVACYT is at this time seeking 500K€ for a bridge before rising 7M€ in Q2 2012 for its international development , knowing that one of the biggest and famous A
- Stage $1M in TTM Revenue
- Industry Medical Devices and Equipment
- Location Vélizy-Villacoublay, IDF, France
- Currency EUR
- Employees 6
- Website novacyt.com
Company Summary
NOVACYT founded in 2006, has developed and commercializes from 2 years now a breakthrough cancer screening solution in the field of liquid based cytology.
The global market of these tests will be of 200M tests in 2015 with a fast growing in the BRICS for which NOVACYT has developed a high quality and affordable test.
Thanks to already marketed and international validated products, NOVACYT is ready to have an offensive strategy in the BRICS.
Team
-
Eric Louis PELTIERCEO
CAREER-EDUCATION:
Awardwinner of the Medical University of Saint Antoine
1991-1995 : Internship at « Hôpitaux de Paris »
1994 : Master in Molecular Biology (Paris VI)
1996 : Medical Doctor degree, Jury’s congratulations
1998 : Master in « Health System and Society » (Paris VII)
2005 : University degree in Coloscopy (Paris)RESEARCH AND TEACHING CHAIRS:
1996 – 1998 : Assistant Paris’s Hospitals & Universities
1998 – 1999 : Physician -
Jean Pierre CRINELLICOO
EDUCATION:
1975 : ESC - Le Havre Business School
1976 : DECS
1993 : HEC/Cesa Strategic Management - Paris Business SchoolPROFESSIONAL EXPERIENCE:
1977 - 1984 : COMPAGNIE EUROPEENNE D’ACCUMULATEURS (CEAc)
*1983 - 1984 : Director International Affaires
*1982 : Managing Director Fulmen UK & Hollande
*1979 - 1981 : Sales Manager OEM outside France
Advisors
-
LAVOIXLawyerUnconfirmedREVISAAccountantUnconfirmed
Previous Investors
-
AURINVEST 2Unconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.